{
  "ticker": "ACAD",
  "company_name": "ACADIA Pharmaceuticals",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05796167",
      "title": "Pimavanserin for Sleep in Parkinson Disease",
      "status": "WITHDRAWN",
      "phase": "EARLY_PHASE1",
      "condition": "Parkinson Disease",
      "start_date": "2023-01-27",
      "completion_date": "2024-06-24",
      "enrollment": 0,
      "sponsor": "State University of New York - Downstate Medical Center"
    },
    {
      "nct_id": "NCT00361166",
      "title": "Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2005-08",
      "completion_date": "2007-03",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT02970305",
      "title": "Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2016-11-04",
      "completion_date": "2019-10-28",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05895513",
      "title": "Pimavanserin and Aggression and Social Cognition.",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Intermittent Explosive Disorder",
      "start_date": "2024-08-01",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "Ohio State University"
    },
    {
      "nct_id": "NCT05357612",
      "title": "Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis",
      "start_date": "2023-01-23",
      "completion_date": "2026-08",
      "enrollment": 0,
      "sponsor": "Vanderbilt University Medical Center"
    },
    {
      "nct_id": "NCT07029581",
      "title": "Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Lewy Body Dementia Psychosis",
      "start_date": "2025-08-06",
      "completion_date": "2028-03",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03118947",
      "title": "A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Agitation and Aggression in Alzheimer's Disease",
      "start_date": "2017-02-23",
      "completion_date": "2019-02-25",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT00490516",
      "title": "ACP-104 in Acutely Psychotic Subjects With Schizophrenia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2007-06",
      "completion_date": "2008-02",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT01174004",
      "title": "A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Parkinson's Disease Psychosis",
      "start_date": "2010-07",
      "completion_date": "2012-11",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT06173531",
      "title": "Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Hyperphagia in Prader-Willi Syndrome",
      "start_date": "2023-11-27",
      "completion_date": "2025-11",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "EARLY_PHASE1": 1,
      "PHASE2": 19,
      "PHASE4": 3,
      "PHASE3": 19,
      "PHASE1": 1,
      "": 3,
      "PHASE2, PHASE3": 4
    },
    "by_status": {
      "WITHDRAWN": 3,
      "COMPLETED": 27,
      "RECRUITING": 6,
      "ACTIVE_NOT_RECRUITING": 1,
      "ENROLLING_BY_INVITATION": 3,
      "TERMINATED": 9,
      "APPROVED_FOR_MARKETING": 1
    },
    "active_trials": 10,
    "completed_trials": 27,
    "conditions": [
      "Acute Postoperative Pain, Bunionectomy",
      "Adjunctive Treatment of Major Depressive Disorder",
      "Agitation and Aggression in Alzheimer's Disease",
      "Alzheimer's Disease Psychosis",
      "Autism Spectrum Disorder",
      "Dementia-related Psychosis",
      "Hallucinations, Psychoses, Parkinson's Disease",
      "Hyperphagia in Prader-Willi Syndrome",
      "Insomnia Chronic, Posttraumatic Stress Disorder",
      "Intermittent Explosive Disorder",
      "Irritability Associated With Autism Spectrum Disorder",
      "Lewy Body Dementia Psychosis",
      "Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant",
      "Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis",
      "Neuropsychiatric Symptoms Related to Neurodegenerative Disease",
      "Osteoarthritis Pain",
      "Parkinson Disease",
      "Parkinson Disease Psychosis",
      "Parkinson Disease, Parkinson Disease Psychosis, Hallucinations, Delusion",
      "Parkinson's Disease",
      "Parkinson's Disease Psychosis",
      "Rett Syndrome",
      "Schizophrenia",
      "Schizophrenia, Psychosis",
      "Treatment of Depression in Adults With Parkinson's Disease (PD)"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-05T17:58:23.485874",
    "search_query": "ACADIA Pharmaceuticals",
    "url": "https://clinicaltrials.gov/search?term=ACADIA+Pharmaceuticals"
  }
}